<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03357393</url>
  </required_header>
  <id_info>
    <org_study_id>BRONSE</org_study_id>
    <nct_id>NCT03357393</nct_id>
  </id_info>
  <brief_title>Patient-controlled Sedation With Propofol Versus Combined Sedation During Bronchoscopy</brief_title>
  <official_title>Patient-controlled Sedation With Propofol Versus Combined Sedation During Bronchoscopy - a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lena Nilsson</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Linkoeping</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      bronchoscopy - a randomized controlled trial&quot; (EudraCT number: 2015-005274-38, protocol&#xD;
      number: &quot;BRONSE&quot;) is a phase IV single centre prospective randomized controlled trial with&#xD;
      parallel groups. A total of 150 adult outpatients undergo diagnostic bronchoscopy during&#xD;
      sedation and are randomized into three sedation arms (1:1:1); sedation with midazolam and&#xD;
      morphine-scopolamine as premedication (clinical routine), sedation with propofol using PCS&#xD;
      and morphine-scopolamine as premedication, and sedation with propofol using PCS and&#xD;
      glycopyrronium bromide as premedication. The study is partially blinded, the bronchoscopist&#xD;
      is blinded regarding given premedication for patients given PCS (two sedation arms). The&#xD;
      hypothesis is that PCS increase the amount of patients ready for discharge, and further that&#xD;
      patient characteristics affect the amount of propofol administered. The endpoints are&#xD;
      primarily the amount of patients ready for discharge within 2 hours and secondary assessment&#xD;
      of patient recovery and satisfaction as well as bronchoscopist evaluation and doses of&#xD;
      administrated drugs. Finally safety variables are collected such as vital signs and&#xD;
      interventions performed to maintain cardiovascular and respiratory stability.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 4, 2016</start_date>
  <completion_date type="Actual">May 9, 2017</completion_date>
  <primary_completion_date type="Actual">May 9, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
    <masking_description>The bronchoscopist is blinded regarding given premedication for patients given PCS (two sedation arms).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Discharge Assessment Using PADSS After 2 Hours Number of Patients Reaching PADSS Score 10 After 2 Hours</measure>
    <time_frame>2 hours after bronchoscopy is finished</time_frame>
    <description>Post Anaesthetic Discharge Scoring System (PADSS).A measurement of the PADSS score is done by pulmonary nurse every 15 min after bronchoscopy is finished (when bronchoscope is removed) for 2 hours. The PADSS is used to clinically assess if the patient is ready to be discharged after anaesthesia/sedation and consist of five criteria: vital signs, ambulation, nausea and/or vomiting, pain and surgical bleeding. Each criterion is given a score ranging from 0 to 2. Only patients who achieve a total score of 10 are considered ready for discharge after 2 hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of Self-rated Patient Questionaries' Using S-PSR</measure>
    <time_frame>The assessment is done by the patient at home (or at ward if pro-longed hospital stay is necessary) in the evening on the day of bronchoscopy. It takes approximately 2 minutes to complete the questionnaire.</time_frame>
    <description>Post-discharge Surgical Recovery Scale (S-PSR) The modified Swedish version S-PSR is based on the &quot;Post-discharge Surgical Recovery Scale&quot; and is a 14-item questionnaire to assess the recovery post-discharge regarding the patients' health status and activity (see further appendix 2). Each item is rated using a semantic differential scale and the total sum is multiplied by 100. The possible range is 10-100, with higher score indicating a more favourable postoperative recovery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Recovery (QoR-23)</measure>
    <time_frame>The assessment is done by the patient at home (or at ward if pro-longed hospital stay is necessary) in the morning the day after bronchoscopy. It takes less than 1 minute to complete the assessment.</time_frame>
    <description>Modified version of Quality of Recovery (QoR-23) Minimum value 23. Maximum value 115. A higher score indicate a better quality of recovery.&#xD;
The questionnaire &quot;Quality of Recovery&quot; (QoR-23) is a 23 item questionnaire to assess recovery after day surgery regarding the patients' emotional state, physical comfort and physical independence (see further appendix 4). Each item is rated on a five-point scale (1-5) and the scores are summed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients' Satisfaction Using a Likert-type Scale</measure>
    <time_frame>After patient has recovered after bronchoscopy and before discharge home, estimated period of time 0-24 hours.</time_frame>
    <description>overall satisfaction with the procedure using the Likert-type scale (1. Very dissatisfied, 2. Dissatisfied, 3. Neither satisfied nor dissatisfied, 4. Satisfied, 5. Very satisfied). The patient may comment any cause which made the satisfaction score high or low and if the patient would like to receive the same method of sedation during a future bronchoscopy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bronchoscopist Evaluation Using a Likert-type Scale</measure>
    <time_frame>Directly after completion of the procedure.</time_frame>
    <description>the bronchoscopist assess their perception of cough, bronchial secretion respectively circumstances for a smooth performance of the bronchoscopy of procedure using the Likert-type scale (1. Very dissatisfied, 2. Dissatisfied, 3. Neither satisfied nor dissatisfied, 4. Satisfied, 5. Very satisfied).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Level of Sedation Using the Observer's Assessment of Alertness/Sedation (OAA/S) Scale</measure>
    <time_frame>Assessement are done every 5th minute from procedure start until end of procedure (extraction of bronchoscope), estimated period of time 0-60 minutes.</time_frame>
    <description>Level of sedation is assessed every 5th minute during the procedure by the nurse anaesthetist using The Observer's Assessment of Alertness/Sedation (OAA/S) scale whereby a higher score represent a lighter sedation. Below is the scale descriped, Observation/score:&#xD;
Responds readily to name spoken in normal tone/5 Lethargic response to name spoken in normal tone/4 Responds only after name is called loudly and/or repeatedly/3 Responds only after mild prodding or shaking/2 Does not respond to mild prodding or shaking/1</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Participants With Interventions Performed</measure>
    <time_frame>From procedure start until end of procedure (extraction of bronchoscope), estimated period of time 0-60 minutes.</time_frame>
    <description>Number of participants with interventions performed to maintain cardiovascular (if atropine or ephidrine has been given) and respiratory stability (if assisted ventilation, chin lift or painful stimulation has been performed). Assesed every five minutes during the procedure.</description>
  </other_outcome>
  <other_outcome>
    <measure>Arterial Oxygen Saturation (SpO2)</measure>
    <time_frame>Every five minutes during the procedure (from procedure start until end of procedure (extraction of bronchoscope), , estimated period of time 0-60 minutes, and thereafter after the procedure every 15 minutes until PADSS score ≥9 or maximum 4 hours.</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Respiratory Rate Per Minute (RR)</measure>
    <time_frame>Every five minutes during the procedure (from procedure start until end of procedure (extraction of bronchoscope), , estimated period of time 0-60 minutes, and thereafter after the procedure every 15 minutes until PADSS score ≥9 or maximum 4 hours.</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Non-invasive Blood Pressure (mmHg)</measure>
    <time_frame>Every five minutes during the procedure (from procedure start until end of procedure (extraction of bronchoscope), , estimated period of time 0-60 minutes, and thereafter after the procedure every 15 minutes until PADSS score ≥9 or maximum 4 hours.</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Heart Rate (Beats Per Minute, HR).</measure>
    <time_frame>Every five minutes during the procedure (from procedure start until end of procedure (extraction of bronchoscope), , estimated period of time 0-60 minutes, and thereafter after the procedure every 15 minutes until PADSS score ≥9 or maximum 4 hours.</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Sedation, Bronchoscopy</condition>
  <arm_group>
    <arm_group_label>Midazolam and morphine-scopolamine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sedation during bronchoscopy with midazolam and morphine-scopolamine as premedication.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCS (propofol) with morphine-scopolamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sedation during bronchoscopy with propofol using PCS and morphine-scopolamine as premedication</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCS (propofol) with glycopyrronium bromide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sedation during bronchoscopy with propofol using PCS and glycopyrronium bromide as premedication.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Midazolam is givenas sedation to the Control arm.</description>
    <arm_group_label>Midazolam and morphine-scopolamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol-Lipuro</intervention_name>
    <description>Propofol is given as sedation to both intervention arms.</description>
    <arm_group_label>PCS (propofol) with glycopyrronium bromide</arm_group_label>
    <arm_group_label>PCS (propofol) with morphine-scopolamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>morphine-scopolamine</intervention_name>
    <description>Given as premedication for the Control arm and one of the interventions arms.</description>
    <arm_group_label>Midazolam and morphine-scopolamine</arm_group_label>
    <arm_group_label>PCS (propofol) with morphine-scopolamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glycopyrrolate</intervention_name>
    <description>Given as premedication for one of the intervention arms..</description>
    <arm_group_label>PCS (propofol) with glycopyrronium bromide</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patient (≥18 years)&#xD;
&#xD;
          -  Planned bronchoscopic procedure with sedation in an outpatient setting&#xD;
&#xD;
          -  The patient have after receiving information about the study given his/her signed&#xD;
             informed consent to participate.&#xD;
&#xD;
          -  Women of childbearing potential only if use of effective contraceptive.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Positive pregnancy test S-β-HCG.&#xD;
&#xD;
          -  Known/suspected allergy or contraindication* to any medication within the study.&#xD;
&#xD;
          -  Functional disability in both hands which affect the possibility to operate the PCS&#xD;
             device.&#xD;
&#xD;
          -  Cognitive impairment, unwillingness or language difficulties resulting in difficulty&#xD;
             to understand the meaning of participation in the study or to operate the PCS device.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 7, 2017</study_first_submitted>
  <study_first_submitted_qc>November 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2017</study_first_posted>
  <results_first_submitted>December 4, 2020</results_first_submitted>
  <results_first_submitted_qc>December 31, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 5, 2021</results_first_posted>
  <last_update_submitted>December 31, 2020</last_update_submitted>
  <last_update_submitted_qc>December 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Linkoeping</investigator_affiliation>
    <investigator_full_name>Lena Nilsson</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Glycopyrrolate</mesh_term>
    <mesh_term>Scopolamine</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Butylscopolammonium Bromide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 29, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/93/NCT03357393/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Midazolam and Morphine-scopolamine</title>
          <description>Sedation during bronchoscopy with midazolam and morphine-scopolamine as premedication.&#xD;
Midazolam: Midazolam is givenas sedation to the Control arm.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
        </group>
        <group group_id="P2">
          <title>PCS (Propofol) With Morphine-scopolamine</title>
          <description>Sedation during bronchoscopy with propofol using PCS and morphine-scopolamine as premedication&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
        </group>
        <group group_id="P3">
          <title>PCS (Propofol) With Glycopyrronium Bromide</title>
          <description>Sedation during bronchoscopy with propofol using PCS and glycopyrronium bromide as premedication.&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
Glycopyrrolate: Given as premedication for one of the intervention arms..</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
                <participants group_id="P3" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
                <participants group_id="P3" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Midazolam and Morphine-scopolamine</title>
          <description>Sedation during bronchoscopy with midazolam and morphine-scopolamine as premedication.&#xD;
Midazolam: Midazolam is givenas sedation to the Control arm.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
        </group>
        <group group_id="B2">
          <title>PCS (Propofol) With Morphine-scopolamine</title>
          <description>Sedation during bronchoscopy with propofol using PCS and morphine-scopolamine as premedication&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
        </group>
        <group group_id="B3">
          <title>PCS (Propofol) With Glycopyrronium Bromide</title>
          <description>Sedation during bronchoscopy with propofol using PCS and glycopyrronium bromide as premedication.&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
Glycopyrrolate: Given as premedication for one of the intervention arms..</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="50"/>
            <count group_id="B4" value="150"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="50"/>
                    <count group_id="B4" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70" lower_limit="33" upper_limit="83"/>
                    <measurement group_id="B2" value="69" lower_limit="25" upper_limit="86"/>
                    <measurement group_id="B3" value="68" lower_limit="25" upper_limit="89"/>
                    <measurement group_id="B4" value="69" lower_limit="25" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="50"/>
                    <count group_id="B4" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="28"/>
                    <measurement group_id="B4" value="72"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Sweden</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="50"/>
                    <count group_id="B4" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="50"/>
                    <measurement group_id="B4" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Discharge Assessment Using PADSS After 2 Hours Number of Patients Reaching PADSS Score 10 After 2 Hours</title>
        <description>Post Anaesthetic Discharge Scoring System (PADSS).A measurement of the PADSS score is done by pulmonary nurse every 15 min after bronchoscopy is finished (when bronchoscope is removed) for 2 hours. The PADSS is used to clinically assess if the patient is ready to be discharged after anaesthesia/sedation and consist of five criteria: vital signs, ambulation, nausea and/or vomiting, pain and surgical bleeding. Each criterion is given a score ranging from 0 to 2. Only patients who achieve a total score of 10 are considered ready for discharge after 2 hours.</description>
        <time_frame>2 hours after bronchoscopy is finished</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Midazolam and Morphine-scopolamine</title>
            <description>Sedation during bronchoscopy with midazolam and morphine-scopolamine as premedication.&#xD;
Midazolam: Midazolam is givenas sedation to the Control arm.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
          </group>
          <group group_id="O2">
            <title>PCS (Propofol) With Morphine-scopolamine</title>
            <description>Sedation during bronchoscopy with propofol using PCS and morphine-scopolamine as premedication&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
          </group>
          <group group_id="O3">
            <title>PCS (Propofol) With Glycopyrronium Bromide</title>
            <description>Sedation during bronchoscopy with propofol using PCS and glycopyrronium bromide as premedication.&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
Glycopyrrolate: Given as premedication for one of the intervention arms..</description>
          </group>
        </group_list>
        <measure>
          <title>Discharge Assessment Using PADSS After 2 Hours Number of Patients Reaching PADSS Score 10 After 2 Hours</title>
          <description>Post Anaesthetic Discharge Scoring System (PADSS).A measurement of the PADSS score is done by pulmonary nurse every 15 min after bronchoscopy is finished (when bronchoscope is removed) for 2 hours. The PADSS is used to clinically assess if the patient is ready to be discharged after anaesthesia/sedation and consist of five criteria: vital signs, ambulation, nausea and/or vomiting, pain and surgical bleeding. Each criterion is given a score ranging from 0 to 2. Only patients who achieve a total score of 10 are considered ready for discharge after 2 hours.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
                <count group_id="O3" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessment of Self-rated Patient Questionaries' Using S-PSR</title>
        <description>Post-discharge Surgical Recovery Scale (S-PSR) The modified Swedish version S-PSR is based on the &quot;Post-discharge Surgical Recovery Scale&quot; and is a 14-item questionnaire to assess the recovery post-discharge regarding the patients' health status and activity (see further appendix 2). Each item is rated using a semantic differential scale and the total sum is multiplied by 100. The possible range is 10-100, with higher score indicating a more favourable postoperative recovery.</description>
        <time_frame>The assessment is done by the patient at home (or at ward if pro-longed hospital stay is necessary) in the evening on the day of bronchoscopy. It takes approximately 2 minutes to complete the questionnaire.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Midazolam and Morphine-scopolamine</title>
            <description>Sedation during bronchoscopy with midazolam and morphine-scopolamine as premedication.&#xD;
Midazolam: Midazolam is givenas sedation to the Control arm.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
          </group>
          <group group_id="O2">
            <title>PCS (Propofol) With Morphine-scopolamine</title>
            <description>Sedation during bronchoscopy with propofol using PCS and morphine-scopolamine as premedication&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
          </group>
          <group group_id="O3">
            <title>PCS (Propofol) With Glycopyrronium Bromide</title>
            <description>Sedation during bronchoscopy with propofol using PCS and glycopyrronium bromide as premedication.&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
Glycopyrrolate: Given as premedication for one of the intervention arms..</description>
          </group>
        </group_list>
        <measure>
          <title>Assessment of Self-rated Patient Questionaries' Using S-PSR</title>
          <description>Post-discharge Surgical Recovery Scale (S-PSR) The modified Swedish version S-PSR is based on the &quot;Post-discharge Surgical Recovery Scale&quot; and is a 14-item questionnaire to assess the recovery post-discharge regarding the patients' health status and activity (see further appendix 2). Each item is rated using a semantic differential scale and the total sum is multiplied by 100. The possible range is 10-100, with higher score indicating a more favourable postoperative recovery.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
                <count group_id="O3" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55" lower_limit="36" upper_limit="77"/>
                    <measurement group_id="O2" value="56" lower_limit="43" upper_limit="73"/>
                    <measurement group_id="O3" value="54" lower_limit="41" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Recovery (QoR-23)</title>
        <description>Modified version of Quality of Recovery (QoR-23) Minimum value 23. Maximum value 115. A higher score indicate a better quality of recovery.&#xD;
The questionnaire &quot;Quality of Recovery&quot; (QoR-23) is a 23 item questionnaire to assess recovery after day surgery regarding the patients' emotional state, physical comfort and physical independence (see further appendix 4). Each item is rated on a five-point scale (1-5) and the scores are summed.</description>
        <time_frame>The assessment is done by the patient at home (or at ward if pro-longed hospital stay is necessary) in the morning the day after bronchoscopy. It takes less than 1 minute to complete the assessment.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Midazolam and Morphine-scopolamine</title>
            <description>Sedation during bronchoscopy with midazolam and morphine-scopolamine as premedication.&#xD;
Midazolam: Midazolam is givenas sedation to the Control arm.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
          </group>
          <group group_id="O2">
            <title>PCS (Propofol) With Morphine-scopolamine</title>
            <description>Sedation during bronchoscopy with propofol using PCS and morphine-scopolamine as premedication&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
          </group>
          <group group_id="O3">
            <title>PCS (Propofol) With Glycopyrronium Bromide</title>
            <description>Sedation during bronchoscopy with propofol using PCS and glycopyrronium bromide as premedication.&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
Glycopyrrolate: Given as premedication for one of the intervention arms..</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Recovery (QoR-23)</title>
          <description>Modified version of Quality of Recovery (QoR-23) Minimum value 23. Maximum value 115. A higher score indicate a better quality of recovery.&#xD;
The questionnaire &quot;Quality of Recovery&quot; (QoR-23) is a 23 item questionnaire to assess recovery after day surgery regarding the patients' emotional state, physical comfort and physical independence (see further appendix 4). Each item is rated on a five-point scale (1-5) and the scores are summed.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
                <count group_id="O3" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="61" upper_limit="112"/>
                    <measurement group_id="O2" value="102" lower_limit="60" upper_limit="115"/>
                    <measurement group_id="O3" value="100" lower_limit="63" upper_limit="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patients' Satisfaction Using a Likert-type Scale</title>
        <description>overall satisfaction with the procedure using the Likert-type scale (1. Very dissatisfied, 2. Dissatisfied, 3. Neither satisfied nor dissatisfied, 4. Satisfied, 5. Very satisfied). The patient may comment any cause which made the satisfaction score high or low and if the patient would like to receive the same method of sedation during a future bronchoscopy.</description>
        <time_frame>After patient has recovered after bronchoscopy and before discharge home, estimated period of time 0-24 hours.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Midazolam and Morphine-scopolamine</title>
            <description>Sedation during bronchoscopy with midazolam and morphine-scopolamine as premedication.&#xD;
Midazolam: Midazolam is givenas sedation to the Control arm.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
          </group>
          <group group_id="O2">
            <title>PCS (Propofol) With Morphine-scopolamine</title>
            <description>Sedation during bronchoscopy with propofol using PCS and morphine-scopolamine as premedication&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
          </group>
          <group group_id="O3">
            <title>PCS (Propofol) With Glycopyrronium Bromide</title>
            <description>Sedation during bronchoscopy with propofol using PCS and glycopyrronium bromide as premedication.&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
Glycopyrrolate: Given as premedication for one of the intervention arms..</description>
          </group>
        </group_list>
        <measure>
          <title>Patients' Satisfaction Using a Likert-type Scale</title>
          <description>overall satisfaction with the procedure using the Likert-type scale (1. Very dissatisfied, 2. Dissatisfied, 3. Neither satisfied nor dissatisfied, 4. Satisfied, 5. Very satisfied). The patient may comment any cause which made the satisfaction score high or low and if the patient would like to receive the same method of sedation during a future bronchoscopy.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
                <count group_id="O3" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2" upper_limit="5"/>
                    <measurement group_id="O2" value="5" lower_limit="4" upper_limit="5"/>
                    <measurement group_id="O3" value="5" lower_limit="4" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Bronchoscopist Evaluation Using a Likert-type Scale</title>
        <description>the bronchoscopist assess their perception of cough, bronchial secretion respectively circumstances for a smooth performance of the bronchoscopy of procedure using the Likert-type scale (1. Very dissatisfied, 2. Dissatisfied, 3. Neither satisfied nor dissatisfied, 4. Satisfied, 5. Very satisfied).</description>
        <time_frame>Directly after completion of the procedure.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Midazolam and Morphine-scopolamine</title>
            <description>Sedation during bronchoscopy with midazolam and morphine-scopolamine as premedication.&#xD;
Midazolam: Midazolam is givenas sedation to the Control arm.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
          </group>
          <group group_id="O2">
            <title>PCS (Propofol) With Morphine-scopolamine</title>
            <description>Sedation during bronchoscopy with propofol using PCS and morphine-scopolamine as premedication&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
          </group>
          <group group_id="O3">
            <title>PCS (Propofol) With Glycopyrronium Bromide</title>
            <description>Sedation during bronchoscopy with propofol using PCS and glycopyrronium bromide as premedication.&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
Glycopyrrolate: Given as premedication for one of the intervention arms..</description>
          </group>
        </group_list>
        <measure>
          <title>Bronchoscopist Evaluation Using a Likert-type Scale</title>
          <description>the bronchoscopist assess their perception of cough, bronchial secretion respectively circumstances for a smooth performance of the bronchoscopy of procedure using the Likert-type scale (1. Very dissatisfied, 2. Dissatisfied, 3. Neither satisfied nor dissatisfied, 4. Satisfied, 5. Very satisfied).</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
                <count group_id="O3" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="2" upper_limit="5"/>
                    <measurement group_id="O2" value="4" lower_limit="1" upper_limit="5"/>
                    <measurement group_id="O3" value="4" lower_limit="2" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Level of Sedation Using the Observer's Assessment of Alertness/Sedation (OAA/S) Scale</title>
        <description>Level of sedation is assessed every 5th minute during the procedure by the nurse anaesthetist using The Observer's Assessment of Alertness/Sedation (OAA/S) scale whereby a higher score represent a lighter sedation. Below is the scale descriped, Observation/score:&#xD;
Responds readily to name spoken in normal tone/5 Lethargic response to name spoken in normal tone/4 Responds only after name is called loudly and/or repeatedly/3 Responds only after mild prodding or shaking/2 Does not respond to mild prodding or shaking/1</description>
        <time_frame>Assessement are done every 5th minute from procedure start until end of procedure (extraction of bronchoscope), estimated period of time 0-60 minutes.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Midazolam and Morphine-scopolamine</title>
            <description>Sedation during bronchoscopy with midazolam and morphine-scopolamine as premedication.&#xD;
Midazolam: Midazolam is givenas sedation to the Control arm.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
          </group>
          <group group_id="O2">
            <title>PCS (Propofol) With Morphine-scopolamine</title>
            <description>Sedation during bronchoscopy with propofol using PCS and morphine-scopolamine as premedication&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
          </group>
          <group group_id="O3">
            <title>PCS (Propofol) With Glycopyrronium Bromide</title>
            <description>Sedation during bronchoscopy with propofol using PCS and glycopyrronium bromide as premedication.&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
Glycopyrrolate: Given as premedication for one of the intervention arms..</description>
          </group>
        </group_list>
        <measure>
          <title>Level of Sedation Using the Observer's Assessment of Alertness/Sedation (OAA/S) Scale</title>
          <description>Level of sedation is assessed every 5th minute during the procedure by the nurse anaesthetist using The Observer's Assessment of Alertness/Sedation (OAA/S) scale whereby a higher score represent a lighter sedation. Below is the scale descriped, Observation/score:&#xD;
Responds readily to name spoken in normal tone/5 Lethargic response to name spoken in normal tone/4 Responds only after name is called loudly and/or repeatedly/3 Responds only after mild prodding or shaking/2 Does not respond to mild prodding or shaking/1</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
                <count group_id="O3" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O3" value="2" lower_limit="1" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants With Interventions Performed</title>
        <description>Number of participants with interventions performed to maintain cardiovascular (if atropine or ephidrine has been given) and respiratory stability (if assisted ventilation, chin lift or painful stimulation has been performed). Assesed every five minutes during the procedure.</description>
        <time_frame>From procedure start until end of procedure (extraction of bronchoscope), estimated period of time 0-60 minutes.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Midazolam and Morphine-scopolamine</title>
            <description>Sedation during bronchoscopy with midazolam and morphine-scopolamine as premedication.&#xD;
Midazolam: Midazolam is givenas sedation to the Control arm.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
          </group>
          <group group_id="O2">
            <title>PCS (Propofol) With Morphine-scopolamine</title>
            <description>Sedation during bronchoscopy with propofol using PCS and morphine-scopolamine as premedication&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
          </group>
          <group group_id="O3">
            <title>PCS (Propofol) With Glycopyrronium Bromide</title>
            <description>Sedation during bronchoscopy with propofol using PCS and glycopyrronium bromide as premedication.&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
Glycopyrrolate: Given as premedication for one of the intervention arms..</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Interventions Performed</title>
          <description>Number of participants with interventions performed to maintain cardiovascular (if atropine or ephidrine has been given) and respiratory stability (if assisted ventilation, chin lift or painful stimulation has been performed). Assesed every five minutes during the procedure.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
                <count group_id="O3" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Arterial Oxygen Saturation (SpO2)</title>
        <time_frame>Every five minutes during the procedure (from procedure start until end of procedure (extraction of bronchoscope), , estimated period of time 0-60 minutes, and thereafter after the procedure every 15 minutes until PADSS score ≥9 or maximum 4 hours.</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Respiratory Rate Per Minute (RR)</title>
        <time_frame>Every five minutes during the procedure (from procedure start until end of procedure (extraction of bronchoscope), , estimated period of time 0-60 minutes, and thereafter after the procedure every 15 minutes until PADSS score ≥9 or maximum 4 hours.</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Non-invasive Blood Pressure (mmHg)</title>
        <time_frame>Every five minutes during the procedure (from procedure start until end of procedure (extraction of bronchoscope), , estimated period of time 0-60 minutes, and thereafter after the procedure every 15 minutes until PADSS score ≥9 or maximum 4 hours.</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Heart Rate (Beats Per Minute, HR).</title>
        <time_frame>Every five minutes during the procedure (from procedure start until end of procedure (extraction of bronchoscope), , estimated period of time 0-60 minutes, and thereafter after the procedure every 15 minutes until PADSS score ≥9 or maximum 4 hours.</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From start preparation for bronchospcpy (first drug given) to completing the questionnary QoR-23 on the day after procedure</time_frame>
      <desc>In the incident report the following grading is used to rate the severity of an incidence:&#xD;
Mild = aware of the symptoms but they are tolerable&#xD;
Moderate = symptoms partially affect daily activities&#xD;
Severe = symptoms significantly affect daily activities&#xD;
The investigator assesses the relationship between the incidence and the study, as defined:&#xD;
• Likely = good reasons and sufficient documentation to suspect caus</desc>
      <group_list>
        <group group_id="E1">
          <title>Midazolam and Morphine-scopolamine</title>
          <description>Sedation during bronchoscopy with midazolam and morphine-scopolamine as premedication.&#xD;
Midazolam: Midazolam is givenas sedation to the Control arm.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
        </group>
        <group group_id="E2">
          <title>PCS (Propofol) With Morphine-scopolamine</title>
          <description>Sedation during bronchoscopy with propofol using PCS and morphine-scopolamine as premedication&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
morphine-scopolamine: Given as premedication for the Control arm and one of the interventions arms.</description>
        </group>
        <group group_id="E3">
          <title>PCS (Propofol) With Glycopyrronium Bromide</title>
          <description>Sedation during bronchoscopy with propofol using PCS and glycopyrronium bromide as premedication.&#xD;
Propofol-Lipuro: Propofol is given as sedation to both intervention arms.&#xD;
Glycopyrrolate: Given as premedication for one of the intervention arms..</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>bradycardia</sub_title>
                <description>Severe short bradycardia during sedaation. Required pharmacological treatment</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Overnight admission</sub_title>
                <description>Unplanned overnight admission</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="50"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Dizzyness, confusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="50"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lena Nilsson</name_or_title>
      <organization>Region Östergötland</organization>
      <phone>+46 10 103 00 00 ext 1838</phone>
      <email>lena.nilsson@regionostergotland.se</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

